Amwill Health Care Share News - Latest Updates, Live News & More

Latest news about Amwill Health Care

Amwill Health Care shareholders approve FY26 accounts, reappoint MDs 9 days ago

Amwill Health Care Limited held its 9th AGM on August 14, 2026, where shareholders approved FY26 financials and dividends. The board saw the reappointment of Ms. Sapna Parmar as a director and Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors. No adverse remarks were noted in the secretarial audit report.

Amwill Health Care sets ₹33cr investment limits across assets Aug 08, 2026

Amwill Health Care opens ₹2 crore FD with Vysya Co-operative Bank Jul 23, 2026

Amwill Health Care AGM scheduled for Aug 14, 2026 Jul 23, 2026

Amwill Health Care FY26 net profit rises 79% to ₹1,142.13 lakh May 30, 2026

More news about Amwill Health Care

08Apr 26

Amwill Health Care Successfully Recovers from IT Security Incident, Reconstructs UPSI Database

Amwill Health Care Limited has successfully recovered from an IT security incident that occurred on February 18, 2026, implementing comprehensive containment and remediation measures. The company reconstructed lost Structured Digital Database (SDD) data covering July 31, 2025 to February 18, 2026, and obtained PCS certification from Mr. Saurabh Talwar confirming all UPSI entries have been completed and updated for regulatory compliance.

16Jan 26

Amwill Health Care Approves ₹5.25 Crore Investment in AIF and Government Securities

Amwill Health Care Limited's Investment Committee approved investments worth ₹5.25 crores on January 16, 2026, comprising ₹3.00 crores in Vivriti Fixed Income Fund (Category II AIF) and ₹2.25 crores in Government Securities. These investments from internal accruals aim to support financial growth, operational objectives, and long-term strategy without involving related party transactions.

05Nov 25

Amwill Healthcare Reports 40% Profit Decline in H1 FY2026, Utilizes 67% of IPO Proceeds

Amwill Health Care's unaudited financial results for H1 FY2026 show a 40.55% decrease in profit to ₹387.40 lakhs, with revenue falling 8.43% to ₹2,120.50 lakhs. Total expenses increased by 19.59% to ₹1,733.90 lakhs, while earnings per share dropped 53.59% to ₹1.94. The company has utilized 67.27% of its IPO proceeds, with no deviations from the stated objectives. The remaining funds are invested in term deposits and current accounts.

30Jun 25

Amwill Health Care Announces Major Expansion Across Key Indian Markets

Amwill Health Care has revealed plans for significant business expansion into multiple Indian states including Maharashtra, Tamil Nadu, North East India, Chhattisgarh, and Madhya Pradesh. This strategic move aims to extend the company's reach and services to a broader customer base across diverse regions of India. The expansion targets a mix of developed and emerging markets, potentially tapping into underserved healthcare sectors and catering to varied demographics and healthcare needs.

Amwill Health Care

43.50

0.0

(0.0%)

1 Year Returns:-29.84%

Industry Peers

Sun Pharmaceutical

1,902.40

(-0.08%)

Divis Laboratories

8,597.00

(+0.32%)

Torrent Pharmaceuticals

4,896.50

(-2.17%)

Cipla

1,432.20

(-0.40%)

Zydus Life Science

1,120.00

(+1.11%)

Lupin

2,201.80

(+0.01%)

Mankind Pharma

2,384.00

(-0.04%)

Dr Reddys Laboratories

1,174.70

(-0.45%)

Laurus Labs

1,802.00

(-1.26%)

Aurobindo Pharma

1,621.30

(+0.83%)

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104